APEI

Business Context and Reporting Period

Company: American Public Education, Inc. (APEI)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2025
Business Overview: APEI operates four subsidiary institutions: American Public University System (APUS), Rasmussen University (RU), Hondros College of Nursing (HCN), and Graduate School USA (GSUSA). The company provides online and campus-based postsecondary education and career learning. In July 2025, APEI completed the sale of GSUSA.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Consolidated revenue increased 6.5% year-over-year for both the three and six-month periods, driven by enrollment growth at RU (+7.4%) and HCN (+13.5%) and net course registration growth at APUS (+7.3%).
• Profitability Improvement: Net income surged to $4.5 million (Q2) and $13.4 million (YTD) compared to $0.4 million and $0.9 million in the prior year periods. Operating margins improved to 4.3% (Q2) and 5.9% (YTD) from 1.5% and 2.4%, respectively.
• Segment Performance:
  • APUS: Operating income increased to $21.4 million (Q2) and $45.6 million (YTD) due to revenue growth and reduced IT costs.
  • RU: Operating loss narrowed significantly to $(2.0) million (Q2) and $(2.0) million (YTD) from $(8.8) million and $(17.8) million, aided by revenue growth and the absence of prior-year lease termination losses.
  • HCN: Operating loss narrowed to $(0.4) million (Q2) and $(1.1) million (YTD) due to enrollment increases.
• Asset Sales: The company sold assets held for sale (real property) for net proceeds of $23.0 million in the first half of 2025, recording a $1.5 million loss on assets held for sale.
• Preferred Stock Redemption: In June 2025, APEI redeemed all Series A Senior Preferred Stock for $43.1 million, incurring a $3.5 million loss on redemption. This reduced net income available to common stockholders for the quarter to a loss of $0.3 million.

Guidance, Outlook, and Risks

• Planned Combination: APEI announced a planned combination of APUS, RU, and HCN into a single system. While HLC approved the combination in June 2025, implementation may be postponed into the second quarter of 2026 pending dialogue with the Department of Education (ED).
• Regulatory Environment:
  • 90/10 Rule: Changes in TA billing practices to manage the 90/10 ratio may impact cash flow timing and bad debt expense.
  • Financial Responsibility: ED placed the company in the "zone" (composite score of 1.3) for FY 2023. The company elected the "zone alternative," requiring heightened cash monitoring (HCM1) for Title IV disbursements.
  • Legislation: The "One Big Beautiful Bill Act" (OBBBA) signed in July 2025 introduces changes to Title IV programs, including new accountability frameworks and loan limits effective July 2026.
• GSUSA Divestiture: The sale of GSUSA was completed in July 2025 for $0.5 million, expected to result in a loss between $7.0 million and $8.5 million.
• Interest Rate Risk: The company entered a new interest rate cap in January 2025 (notional value $50.0 million) to protect against Term SOFR rates exceeding 5.00%.

Investor Verification Checklist

• Preferred Stock Impact: Verify the impact of the $3.5 million loss on preferred stock redemption on future earnings per share calculations.
• Combination Timeline: Monitor updates on the APUS/RU/HCN combination implementation date, as delays could affect operational synergies and costs.
• Regulatory Compliance: Track the company's compliance with the "zone alternative" financial responsibility standards and the impact of the OBBBA on future Title IV eligibility.
• GSUSA Loss: Confirm the final loss amount on the GSUSA sale in the subsequent 10-Q or 10-K filing.
• Enrollment Trends: Validate continued enrollment growth at RU and HCN, particularly regarding NCLEX pass rates and retention benchmarks which are critical for accreditation.